30 Day Trial

NuVasive 4Q16 and 2016 Revenue


NuVasive reported 2016 revenue of US $962.1MM, +18.6% from 2015, with 4Q16 revenue of $271.1MM, +25.9% vs. 4Q15.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.